- Home
- VRCA vs IINN Comparison
VRCA vs IINN Comparison
Compare VRCA & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- IINN
- Stock Information
- Founded
- VRCA 2013
- IINN 2018
- Country
- VRCA United States
- IINN Israel
- Employees
- VRCA N/A
- IINN N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- IINN Medical/Dental Instruments
- Sector
- VRCA Health Care
- IINN Health Care
- Exchange
- VRCA Nasdaq
- IINN Nasdaq
- Market Cap
- VRCA 40.6M
- IINN 33.9M
- IPO Year
- VRCA 2018
- IINN 2021
- Fundamental
- Price
- VRCA $3.96
- IINN $1.12
- Analyst Decision
- VRCA Buy
- IINN Strong Buy
- Analyst Count
- VRCA 4
- IINN 1
- Target Price
- VRCA $60.00
- IINN $2.00
- AVG Volume (30 Days)
- VRCA 348.8K
- IINN 239.7K
- Earning Date
- VRCA 11-06-2025
- IINN 10-01-2025
- Dividend Yield
- VRCA N/A
- IINN N/A
- EPS Growth
- VRCA N/A
- IINN N/A
- EPS
- VRCA N/A
- IINN N/A
- Revenue
- VRCA $14,704,000.00
- IINN $289,000.00
- Revenue This Year
- VRCA $332.45
- IINN N/A
- Revenue Next Year
- VRCA $12.85
- IINN $3,100.00
- P/E Ratio
- VRCA N/A
- IINN N/A
- Revenue Growth
- VRCA 5.72
- IINN N/A
- 52 Week Low
- VRCA $3.82
- IINN $0.40
- 52 Week High
- VRCA $17.38
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- VRCA 39.62
- IINN 44.33
- Support Level
- VRCA $3.93
- IINN $1.14
- Resistance Level
- VRCA $4.54
- IINN $1.21
- Average True Range (ATR)
- VRCA 0.32
- IINN 0.06
- MACD
- VRCA 0.01
- IINN -0.01
- Stochastic Oscillator
- VRCA 11.00
- IINN 22.48
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.